Further, the results for early and advanced adenomatous and cancerous states are given in Fig 10 for a typical Lynch syndrome patient with a germline variant in MLH1. It is important to note that we can analyze, e.g., the relative contribution of MMR-deficient and MMR-proficient adenomatous and cancerous states. Here, MRC1 is linked to Lynch syndrome.